Fujita Health University · Faculty of Medicine / Graduate School of Medicine · 講師

Research keywordsmetastatic renal cell carcinoma・immune checkpoint combinations・tyrosine kinase inhibitors・prostate cancer genomics・biochemical recurrence・salvage radiotherapy・robot-assisted radical prostatectomy・perioperative urologic infections・cystitis antimicrobials・treatment-related eosinophilia

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Impact of Proton Pump Inhibitor Use on the Efficacy of IO-IO Versus IO-TKI Therapy in Metastatic Renal Cell Carcinoma.2026 · Clinical genitourinary cancer
• Genomic Profiling in Localized Prostate Cancer: Associations With Biochemical Recurrence and Response to Salvage Radiotherapy.2026 · Cancer science
• A real-world comparison of nivolumab plus cabozantinib and pembrolizumab plus lenvatinib focusing on safety outcomes in metastatic renal cell carcinoma: results from the JK-FOOT consortium.2026 · Cancer immunology, immunotherapy : CII
• Comparative efficacy of immune checkpoint inhibitor combination therapies by metastatic site in metastatic renal cell carcinoma.2026 · Scientific reports

• Official profile